Literature DB >> 21847001

The negative symptoms of schizophrenia: category or continuum?

Stefan Kaiser1, Karsten Heekeren, Joe J Simon.   

Abstract

Negative symptoms have been considered to be specific to schizophrenia or a subtype of schizophrenia: the deficit syndrome. In other words, these symptoms have been considered to be categorically different from other forms of human behavior and experience, whether they occur in healthy persons or patients with other psychiatric disorders. In this paper, we advocate a dimensional approach to negative symptoms, which is supported by two main arguments. First, enduring negative symptoms can even be observed in a variety of psychiatric disorders and they are not specific to schizophrenia. Second, we review evidence that negative symptoms show a continuous distribution from apparently healthy subjects to those with a fully developed clinical syndrome. Although the evidence does not allow for a definite decision concerning the dimensional distribution of negative symptoms, it certainly justifies exploring a dimensional approach with respect to its clinical and scientific utility. Understanding negative symptoms as a variation of normal mental processes will strengthen the development of neurocognitive models and treatment approaches.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21847001     DOI: 10.1159/000325912

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  14 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

2.  Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With Schizophrenia.

Authors:  Joe J Simon; Sheila A Cordeiro; Marc-André Weber; Hans-Christoph Friederich; Robert C Wolf; Matthias Weisbrod; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2015-05-25       Impact factor: 9.306

3.  Social Withdrawal Among Individuals Receiving Psychiatric Care: Derivation of a Scale Using Routine Clinical Assessment Data to Support Screening and Outcome Measurement.

Authors:  Sebastian Rios; Christopher M Perlman
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

4.  Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning.

Authors:  Buranee Kanchanatawan; Sira Sriswasdi; Supaksorn Thika; Sunee Sirivichayakul; André F Carvalho; Michel Geffard; Marta Kubera; Michael Maes
Journal:  Metab Brain Dis       Date:  2018-03-11       Impact factor: 3.584

5.  Apathy is related to reduced activation in cognitive control regions during set-shifting.

Authors:  Nicky G Klaasen; Claire Kos; André Aleman; Esther M Opmeer
Journal:  Hum Brain Mapp       Date:  2017-03-03       Impact factor: 5.038

Review 6.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

7.  Event-related potentials to rare visual targets and negative symptom severity in a transdiagnostic psychiatric sample.

Authors:  Giulia C Salgari; Geoffrey F Potts; Joseph Schmidt; Chi C Chan; Christopher C Spencer; Jeffrey S Bedwell
Journal:  Clin Neurophysiol       Date:  2021-04-09       Impact factor: 4.861

8.  False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes.

Authors:  Michael Maes; George Anderson
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

9.  Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study.

Authors:  Massimiliano Buoli; Alice Caldiroli; Gabriele Panza; Alfredo Carlo Altamura
Journal:  Psychiatry Investig       Date:  2012-11-14       Impact factor: 2.505

10.  Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data.

Authors:  Elisabetta Caletti; Riccardo A Paoli; Alessio Fiorentini; Michela Cigliobianco; Elisa Zugno; Marta Serati; Giulia Orsenigo; Paolo Grillo; Stefano Zago; Alice Caldiroli; Cecilia Prunas; Francesca Giusti; Dario Consonni; A Carlo Altamura
Journal:  Front Hum Neurosci       Date:  2013-10-17       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.